Sector pending / Medicinal Chemicals and Botanical ProductsUpdated 2026-05-10 22:07 UTC

BOM/524516 stock hub

BOM/524516 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/524516is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

817.1M

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/524516

In the news

Latest news · BOM/524516

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E95

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-0.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/524516 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

135

Groups with data

Currency

INR

Showing 135 of 135 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2
Employees Change	-1%
Employees Change Percent	-33.33
Enterprise value	INR 801.2M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Medicinal Chemicals and Botanical Products
Last refreshed	2026-05-10
Market cap	INR 817.1M
Price	INR 56.93
Price currency	INR
Sic	2833
Symbol	bom/524516
Website	https://bacilpharma.co.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.9%
EV Earnings	108.6x
P/B ratio	3.1x
P/E ratio	95.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	INR 7.4M
Net Income Growth	112.02%
Profit Per Employee	INR 3.7M
Roa5y	-5.28
Roe5y	-64.64
ROIC	-0.74
Roic5y	-13.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	29.5%
Cagr15y	20.15%
Cagr1y	39.27%
Cagr20y	11.01%
Cagr3y	120.73%
Cagr5y	49.17%
EPS Growth	-1.94

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 15.9M
Equity	INR 263.5M
Interest Coverage	-365.8
Net Cash	INR 15.9M
Net Cash By Market Cap	INR 1.95
Net Debt Equity	INR -0.06
Tangible Book Value	INR 263.5M
Tangible Book Value Per Share	INR 19.09
WACC	6.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-116.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,226.06%
1Y total return	39.24%
200-day SMA	42.45
3Y total return	976%
50-day SMA	52.48
50-day SMA vs 200-day SMA	50over200
5Y total return	638.43%
All Time High	62.56
All Time High Change	-9.7%
All Time High Date	2024-12-19
All Time Low	0.92
All Time Low Change	6,040.22%
All Time Low Date	2013-12-17
ATR	3.87
Beta	0.47
Beta1y	0.64
Beta2y	0.04
Ch YTD	58.5
High	58.97
High52	61.8
High52 Date	2026-04-22
High52ch	-7.88%
Low	53.67
Low52	26.69
Low52 Date	2025-11-12
Low52ch	113.3%
Ma50ch	7.65%
Price vs 200-day SMA	33.07%
RSI	55.81
RSI Monthly	67.94
RSI Weekly	61.68
Sharpe ratio	0.05x
Sortino ratio	0.18
Total Return	-116.22%
Tr YTD	58.5
Tr15y	1,469.17%
Tr1m	-2.59%
Tr1w	1.46%
Tr3m	52.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -2.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,320,069%
Shares Insiders	69.4%
Shares Out	14,353,000
Shares Qo Q	-5.31%
Shares Yo Y	116.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,735.3x
Bv Per Share	19.09
Ch10y	1,226.1
Ch15y	1,469.2
Ch1m	-2.59
Ch1w	1.46
Ch1y	39.24
Ch20y	707
Ch3m	52.55
Ch3y	976
Ch5y	638.4
Ch6m	100.6
Change	0.78%
Change From Open	0.78
Close	56.49
Days Gap	0
Depreciation Amortization	-2,750
Dollar Volume	99,172.1
Earnings Date	2026-05-25
EBIT	INR -2.4M
EBITDA	INR -2.4M
EPS	INR 0.6
F Score	1
Fiscal Year End	March
Founded	1,987
Graham Number	16.04366
Graham Upside	-71.6
Income Tax	INR 2.3M
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Ma150	43.61
Ma150ch	29.55%
Ma20	56.85
Ma20ch	-0.63%
Next Earnings Date	2026-05-25
Open	56.49
Position In Range	61.51
Price Date	2026-05-08
Ptbv Ratio	3.1
Relative Volume	0.64x
Tax Rate	23.73%
Tr20y	707%
Tr6m	100.6%
Volume	1,742

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/524516 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/524516 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/524516?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+69.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+116.2%

Negative means the company is buying back shares.

Technical

BOM/524516 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.8

Neutral momentum band

Price vs 200-day MA

+33.1%

50/200-day relationship not available

Beta (5Y)

0.47

Less volatile than the market

Sharpe ratio

0.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/524516

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/524516 stock rating?

bom/524516 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/524516 analysis?

The full report lives at /stocks/bom/524516/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/524516?

The latest report frames bom/524516 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/524516 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.